- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platelet-rich Fibrin in New Zealand
Total 274 results
-
PfizerCompletedNeoplasms | Multiple Myeloma | Lymphoma, Malignant | ThrombocytopeniaUnited States, Argentina, Mexico
-
CTI BioPharmaCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post- Essential Thrombocythemia MyelofibrosisUnited States, Spain, United Kingdom, Hungary, Korea, Republic of, France, Italy, Sweden
-
Baylor College of MedicineBoston Children's Hospital; University of California, San FranciscoActive, not recruitingImmune ThrombocytopeniaUnited States
-
GlaxoSmithKlineCompletedMyelodysplastic SyndromePuerto Rico, United States, Taiwan, Germany, Denmark, Hong Kong, Korea, Republic of, France, United Kingdom, Italy, Brazil
-
Boston Children's HospitalTerrana ITP Research FundCompletedImmune ThrombocytopeniaUnited States, Canada
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Idiopathic MyelofibrosisUnited States, Italy
-
American Thrombosis and Hemostasis NetworkNovo Nordisk A/S; Sanofi; Pfizer; Genentech, Inc.; CSL Behring; Hemophilia of Georgia... and other collaboratorsRecruitingHemophilia | Thrombosis | Thrombophilia | Sickle Cell Disease | Thalassemia | Bleeding Disorder | Von Willebrand Diseases | Factor IX Deficiency | Connective Tissue Disorder | Factor VIII Deficiency | Hematologic Disorder | Rare Bleeding Disorder | Platelet DisorderUnited States
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeCanada, United States, Japan, France, Spain, Mexico, Peru, Brazil, New Zealand, Belgium, China, Germany, Hungary, Israel, Italy, Poland, South Africa, Turkey, India
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
John MascarenhasNational Cancer Institute (NCI); Novartis; Incyte Corporation; Myeloproliferative...TerminatedPrimary Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Canada, United Kingdom
-
PfizerRecruitingPrimary Immune ThrombocytopeniaUnited States, Australia, Canada, Czechia, Poland, Hungary, United Kingdom
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Puerto Rico
-
Incyte CorporationCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicItaly, Germany, Hong Kong, Korea, Republic of, United States, Pakistan, Russian Federation, India, Czech Republic, Hungary, France
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, France, Netherlands, Spain, United Kingdom, Canada
-
American Thrombosis and Hemostasis NetworkTakedaActive, not recruiting
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Taiwan, Italy, Poland, Peru, Canada, Denmark, Germany, Slovakia, Spain, United Kingdom, New Zealand, China, Greece, Hong Kong, Russian Federation, Austria, Netherlands, Czech Republic, France, India, Ukraine, Tunisia, F... and more
-
Alexion PharmaceuticalsCompletedAtypical Hemolytic Uremic SyndromeFrance, United States, Austria, Germany, United Kingdom
-
South Eastern Sydney Local Health DistrictGlaxoSmithKlineUnknownThrombocytopeniaSingapore, Korea, Republic of, Thailand, Turkey, Australia, Colombia, Kuwait, Malaysia, Taiwan, Uruguay
-
OctapharmaCompletedVon Willebrand DiseaseUnited States, Canada, Sweden, Spain, Uruguay, United Kingdom, Portugal, Argentina, Czechia, Germany
-
Bio Products LaboratoryCompletedChronic Idiopathic Thrombocytopenic PurpuraUnited States, India, Argentina
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
Alexion PharmaceuticalsCompletedAtypical Hemolytic Uremic SyndromeFrance, United States, Austria, Germany, United Kingdom
-
Alexion Pharmaceuticals, Inc.TerminatedThrombotic MicroangiopathyUnited States, Belgium, France, Italy, Japan, Spain, Taiwan, United Kingdom, Canada, Korea, Republic of, Netherlands
-
Ajax Therapeutics, Inc.Not yet recruitingPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | PMF | Post-Essential Thrombocythemia Myelofibrosis | PPV-MF | PET-MFUnited States
-
Kezar Life Sciences, Inc.WithdrawnImmune Thrombocytopenia | Autoimmune Hemolytic AnemiaPoland, United States, Australia, Italy, Russian Federation
-
Center Trials & TreatmentOleg MartynenkoTerminatedCOVID-19 | SARS-CoV-2 | Furin | RGMc Processing | Paired Basic Amino Acid Cleaving Enzyme (PACE)India, United States, Ukraine
-
Sobi, Inc.CompletedImmune ThrombocytopeniaUnited States
-
Neufeld, Ellis J, MD, PhDGenentech, Inc.; Biogen; Glaser Pediatric Research Network; Terrana ITP Research...CompletedImmune Thrombocytopenic Purpura (ITP) | Idiopathic Thrombocytopenic Purpura (ITP)United States
-
Principia Biopharma, a Sanofi CompanyActive, not recruitingImmune Thrombocytopenia | Immune Thrombocytopenic PurpuraUnited States, Australia, Bulgaria, Canada, Czechia, Netherlands, Norway, United Kingdom
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseNetherlands, Spain, United States, Belgium, Australia, United Kingdom, Austria, Italy, Bulgaria, Japan, Poland, Germany, India, Canada, Russian Federation, Sweden
-
Mitchell CairoRecruitingHodgkin Lymphoma | Sickle Cell Disease | Acute Leukemia | Beta-Thalassemia | Non-hodgkin Lymphoma | Severe Aplastic Anemia | Diamond Blackfan Anemia | Amegakaryocytic Thrombocytopenia | KostmannUnited States
-
National Cancer Institute (NCI)Active, not recruitingPlasmablastic Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell... and other conditionsUnited States
-
argenxActive, not recruitingPrimary Immune ThrombocytopeniaUnited States, France, Georgia, Germany, Italy, Japan, Poland, Russian Federation, Spain, Turkey, United Kingdom, Argentina, Australia, Bulgaria, Chile, China, Denmark, Greece, Ireland, Israel, Jordan, Korea, Republic of, Mexico, New... and more
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraUnited States, Australia, United Kingdom, Canada, Italy, Denmark, Hungary, Netherlands
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy
-
Margaret RagniNational Heart, Lung, and Blood Institute (NHLBI); Duke University; University...TerminatedVon Willebrand DiseasesUnited States
-
The George InstituteThe University of New South WalesRecruitingHypertension | Intracerebral Haemorrhage (ICH)United Kingdom, Australia, Singapore, Georgia, Netherlands, Nigeria, Sri Lanka, Switzerland, Brazil, Malaysia, Taiwan, Vietnam
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraSpain, United States, Australia, Poland, United Kingdom, Canada, Czechia, Bulgaria, Romania, Austria, Denmark, Hungary, Italy, Netherlands, Norway
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
Novartis PharmaceuticalsCompletedThrombocytopaeniaUnited States, Belgium, Canada, Hong Kong, Argentina, Brazil, Czechia, Germany, Greece, Israel, Netherlands, Spain, Thailand, Hungary, Ireland, Italy, Mexico, Taiwan, Korea, Republic of, Poland, Russian Federation, Puerto Rico
-
Archemix Corp.TerminatedThrombotic Thrombocytopenic Purpura | Thrombotic MicroangiopathyUnited States, Italy, Austria, Canada, United Kingdom
-
SyntaraParexelRecruitingMyelofibrosisTaiwan, Australia, Korea, Republic of, United States
-
SanofiRecruitingThrombotic Thrombocytopenic PurpuraItaly, Belgium, France, Greece, United States, Austria, Canada, Czechia, Germany, Japan, Netherlands, Spain, United Kingdom
-
Progenity, Inc.CompletedHypertension | Renal Insufficiency | Proteinuria | Thrombocytopenia | Preeclampsia | Pulmonary Edema | Impaired Liver FunctionUnited States
-
Novartis PharmaceuticalsCompletedBone Marrow Diseases | Hematologic Diseases | Blood Coagulation Disorders | Hemorrhagic Disorders | Primary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocytosis | Essential Thrombocythemia | Blood Platelet DisordersUnited Kingdom, Belgium, Canada, France, Australia, Netherlands, Spain, Denmark, Ireland, Italy, Germany
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingClassic Hodgkin Lymphoma | Lymphocyte-Rich Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage I Mixed Cellularity... and other conditionsUnited States
-
AmgenCompletedImmune ThrombocytopeniaUnited States, Canada, Belgium, Czechia, Mexico, Turkey, Australia, Spain, France, Israel, Hungary, South Africa, Poland, Russian Federation, United Kingdom, Brazil, Switzerland
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraSpain, Norway, Poland, Czechia, Germany, United States, Austria, Bulgaria, Romania